z-logo
open-access-imgOpen Access
Real-Life Efficacy of Bevacizumab Treatment for Macular Edema Secondary to Central Retinal Vein Occlusion according to Pro Re Nata or Treat-and-Extend Regimen in Eyes with or without Epiretinal Membrane
Author(s) -
Moustafa Hamam,
Neil Lagali,
Elie Abdulnour,
Helen Setterud,
Björn Johansson,
Pierfrancesco Mirabelli
Publication year - 2022
Publication title -
journal of ophthalmology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.818
H-Index - 40
eISSN - 2090-0058
pISSN - 2090-004X
DOI - 10.1155/2022/6288582
Subject(s) - pro re nata , medicine , bevacizumab , macular edema , ophthalmology , visual acuity , epiretinal membrane , regimen , retinal , occlusion , retinal vein , ranibizumab , surgery , vitrectomy , chemotherapy

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom